Recent population studies confirm that migraine is extraordinarily common.
According to the American Migraine Prevalence and Prevention Study the cumulative lifetime incidence of migraine is 43% for women and 18% for men in America. This means that nearly half of all women will experience migraine at some point in their lives.
This remarkably common occurrence of migraine suggests that it may involve relatively minor perturbations of normal brain function. However, a migraine attack is a spectacularly complex brain event, and produces a wide array of neurological and systemic symptoms. Headache is typically its most prominent feature, but migraines may include multiple other symptoms that occur before, during, or after the pain. These symptoms include migraine aura with classical visual, and other sensory and language dysfunctions. Other symptoms including mood change, fatigue, yawning, neck stiffness, polyuria, gastrointestinal disturbance, and a variety of visual, somatic sensory, and cognitive phenomena are among the clinical features that may precede, accompany, or follow the headache.
With constant awareness and “premonitoring” symptoms many patients are able to accurately predict the occurrence of a migraine up to days before it begins. The pathophysiological processes underlying a migraine may therefore be occurring well before the headache, which suggests that preventative intervention is likely the best way to treat migraines.
Promising clinical research has suggested that Enzogenol may be able to help in the management of migraines. Please consult your health practitioner to find out if Enzo Professional may be able to help with your migraine problems.
|
Knowledge Links:
Neurological Foundation of New Zealand
Headache Australia:
Migraine Prevention
Health Insite (Australia):
Migraine
MedlinePlus:Migraine
US NIH: Migraine
|